Clinical Trial: Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase 4, Multicenter, Randomized, Open, Active Drug Comparative Trial to Evaluated the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients

Brief Summary: The purpose of this study is evaluate the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients.

Detailed Summary:
Sponsor: Chong Kun Dang Pharmaceutical

Current Primary Outcome: cure rate of erosion [ Time Frame: 2 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • improvement rate of erosion [ Time Frame: 2 weeks ]
  • improvement rate of erythema [ Time Frame: 2 weeks ]
  • improvement rate of hemorrhage [ Time Frame: 2 weeks ]
  • improvement rate of edema [ Time Frame: 2 weeks ]
  • improvement rate of self symptoms [ Time Frame: 2 weeks ]


Original Secondary Outcome: Same as current

Information By: Chong Kun Dang Pharmaceutical

Dates:
Date Received: September 2, 2014
Date Started: August 2014
Date Completion:
Last Updated: August 21, 2015
Last Verified: August 2015